Unifarm University Consortium (Consorzio Universitario Unifarm, UNIFARM) was founded in Catania in 2002 by Filippo Drago, Professor of Pharmacology at the School of Medicine, University of Catania, in cooperation with the University of Catania and twelve major multinational pharmaceutical companies. In the same year the Research Centre in Clinical Pharmacology, the first in Central and Southern Italy, was inaugurated.
The Board of Directors has appointed the Chairman of the Consortium, on July 27, 2012, Prof. Salvatore Salomone, Associate Professor of Pharmacology at the Department of Clinical and Molecular Biomedicine, Faculty of Medicine, University of Catania.
The main purpose of UNIFARM is to promote, coordinate and conduct basic and practical research in the area of Clinical Pharmacology. UNIFARM does specifically the following:
-plans and manages clinical studies (phase I, II, III and IV), tolerability, bioavailability, bioequivalence, non-profit and observational studies;
-determines the pharmacokinetic profile and metabolic characteristics of drugs by chemical and physical analysis of biological samples;
-performs equivalence tests in vitro;
-acts as CRO (Contract Research Organization): guaranteeing project management, monitoring, quality assurance and reporting;
performs GCP/GLP audits;
-researches and develops new drugs including patenting of the methods of synthesis;
-researches and develops new pharmacological applications including patents for use;
-develops new formulations and their patents;
-prepares pharmaco-toxicological expertises;
-acts as a regulatory consultant;
-provides pharmacovigilance service;
-performs Health Technology Assessment (HTA);
-prepares and reviews Standard Operative Procedure (SOP).